TriSalus Life Sciences, Inc. (TLSI) Revenue History
Annual and quarterly revenue from 2020 to present
TLSI Revenue Over Time (2020–2025)
TLSI Revenue Growth History
4 of 4 years with positive growth- FY2020 revenue growth
- N/A
- FY2021 revenue growth
- N/A
- FY2022 revenue growth
- +47.6%
- FY2023 revenue growth
- +49.3%
- FY2024 revenue growth
- +59.0%
- FY2025 revenue growth
- +53.4%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $8.9M | -2.9% |
| Q4 2025 | $13.2M | +59.8% |
| Q3 2025 | $11.6M | +57.4% |
| Q2 2025 | $11.2M | +52.3% |
| Q1 2025 | $9.2M | +42.0% |
| Q4 2024 | $8.3M | +44.4% |
| Q3 2024 | $7.3M | +41.5% |
| Q2 2024 | $7.4M | +59.7% |
Multi-year avg. share of annual revenue by fiscal quarter
TLSI Revenue Analysis (2020–2025)
Current Revenue & Growth
As of June 28, 2026, TriSalus Life Sciences, Inc. (TLSI) generated trailing twelve-month (TTM) revenue of $44.9 million, reflecting slight decline in growth of -2.9% year-over-year. The most recent quarter (Q1 2026) recorded $8.9 million in revenue, down 32.6% sequentially.
Historical Growth Trajectory
TLSI's historical revenue data shows a 3-year CAGR of +53.9%. TriSalus Life Sciences, Inc.'s highest annual revenue of $45.2 million was recorded in 2025, an all-time high.
Peer Comparison
Compared to Healthcare sector peers — including NVCR (+8.5% YoY), ANGO (+10.7% YoY), and IRTC (+27.4% YoY) — TLSI has underperformed the peer group in revenue growth. Compare TLSI vs NVCR →
TLSI Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| TLSICurrent | $45M | -2.9% | - | -59.7% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 ANGO | $292M | +10.7% | +2.1% | -13.7% | |
 IRTC | $747M | +27.4% | +23.0% | -4.9% | |
 INVA | $425M | +13.6% | +4.8% | 38.5% | |
 CNMD | $1.4B | +4.4% | +9.8% | 10.3% |
TLSI Historical Revenue Data (2020–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $45.2M | +53.4% | $38.2M | 84.6% | $-26,946,000 | -59.7% |
| 2024 | $29.4M | +59.0% | $25.3M | 86.1% | $-36,165,000 | -122.9% |
| 2023 | $18.5M | +49.3% | $15.9M | 85.9% | $-54,475,000 | -294.3% |
| 2022 | $12.4M | +47.6% | $10.1M | 81.8% | $-36,439,000 | -293.9% |
| 2021 | $8.4M | - | $7.2M | 85.8% | $-24,032,000 | -286.1% |
| 2020 | $0 | - | $0 | - | $-108,493 | - |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
6+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
TLSI — Frequently Asked Questions
Quick answers to the most common questions about buying TLSI stock.
Is TLSI's revenue growth accelerating or slowing?
TLSI revenue growth is slowing. TTM revenue is $45M, up -2.9% year-over-year — below the 5-year CAGR of N/A. The deceleration suggests maturing end-markets or increased competition.
What is TLSI's revenue history from 2020 to 2026?
TriSalus Life Sciences, Inc. (TLSI) revenue history spans 2020 to 2026. TTM revenue as of 2026 is $45M, growing at -2.9% YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is TLSI's long-term revenue growth rate (CAGR)?
TriSalus Life Sciences, Inc.'s 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of -2.9% is below this long-term average. CAGR is the most reliable measure of sustained revenue momentum for TLSI.
Why does TLSI's quarterly revenue fluctuate?
TLSI quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. TriSalus Life Sciences, Inc.'s revenue data from 2020 to 2026 shows full historical quarterly detail on this page.
How is TLSI's revenue distributed by segment?
TLSI reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does TLSI's revenue compare to industry peers?
TriSalus Life Sciences, Inc. (TLSI) with TTM revenue of $45M and -2.9% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.